Re: Farmas USA
SNTA:
$SNTA JMP investors survey: overall favorable view of Ganetespib & likelihood of success in interim analysis #ASCO13 twitter.com/AndyBiotech/st…
— Andy Biotech (@AndyBiotech) 30 de mayo de 2013
$SNTA - Upcoming Milestones & Catalysts Timeline twitter.com/AndyBiotech/st…
— Andy Biotech (@AndyBiotech) 30 de mayo de 2013